MSB 0.43% $1.16 mesoblast limited

Gilead vs Mesoblast, page-274

  1. 268 Posts.
    lightbulb Created with Sketch. 41
    It's possible but it sort of needs to work even with co-morbidities... The trial is for ARDS patients <3 days on a ventilator. So the quite ill but not yet absolutely critical. If it's efficacous even for a decent percentage (and not harmful to many / any) it can be approved.

    The FDA and Meosblast could always do a Phase 4 study afterwards

    Phase 4: Studies occurring after FDA has approved a drug for marketing. These including postmarket requirement and commitment studies that are required of or agreed to by the sponsor. These studies gather additional information about a drug's safety, efficacy, or optimal use.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.16
Change
0.005(0.43%)
Mkt cap ! $1.304B
Open High Low Value Volume
$1.15 $1.17 $1.13 $3.743M 3.261M

Buyers (Bids)

No. Vol. Price($)
4 78561 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 114667 4
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.